Continued studies will deepen scientists’ understanding of virus-host interactions at the molecular level and also pave the way for developing better drugs to fight emerging viruses.
Ampcera has an exclusive licensing agreement with PNNL to commercially develop and license a new battery material for applications such as vehicles and personal electronics.
PNNL's “co-scientist” serves as a one-stop AI shop for accelerating scientific discovery. By leveraging AI agents, researchers can explore scientific databases, conduct analyses and request step-by-step plans for testing their hypotheses.
Researchers at PNNL are pursuing new approaches to understand, predict and control the phenome—the collection of biological traits within an organism shaped by its genes and interactions with the environment.
Armed with some of the world’s most advanced instrumentation, researchers at PNNL are working to analyze huge amounts of data and uncover hidden biological connections.
Sergei Kalinin, a joint appointee at the University of Tennessee, Knoxville and PNNL, and Ji-Guang (Jason) Zhang, a PNNL Lab Fellow, are part of the 2024 class of National Academy of Inventors Fellows.
PNNL and one of the world’s largest tire makers will work to develop a commercially viable process that converts ethanol derived from sustainable sources or waste, like recycled tires, to butadiene, synthetic rubber’s main ingredient.